Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
18.18
-0.64 (-3.40%)
At close: Sep 11, 2026, 4:00 PM EDT
18.05
-0.13 (-0.72%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 298 employees as of December 31, 2025. The number of employees increased by 28 or 10.37% compared to the previous year.
Employees
298
Change (1Y)
28
Growth (1Y)
10.37%
Revenue / Employee
$846,480
Profits / Employee
-$740,822
Market Cap
1.62B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 298 | 28 | 10.37% | 298 | 0 |
| Dec 31, 2024 | 270 | 86 | 46.74% | 270 | 0 |
| Dec 31, 2023 | 184 | 77 | 71.96% | 184 | 0 |
| Dec 31, 2022 | 107 | 48 | 81.36% | 107 | 0 |
| Dec 31, 2021 | 59 | 16 | 37.21% | 59 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 415 |
| Intellia Therapeutics | 377 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
SNDX News
- 1 day ago - Syndax Pharmaceuticals Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 7 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Syndax Announces Participation in September Investor Conferences - GlobeNewsWire
- 19 days ago - Citi sees up to 410% upside in 2 biotech stocks: is the risk worth it? - Invezz
- 21 days ago - Syndax price target lowered to $33 from $37 at UBS - TheFly
- 4 weeks ago - Syndax price target lowered to $40 from $44 at JPMorgan - TheFly
- 5 weeks ago - Syndax price target lowered to $38 from $40 at H.C. Wainwright - TheFly
- 5 weeks ago - Syndax Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts